An Open-Label Extension Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects Ages 1 to less than 11 Years: a Long Term Study.

Trial Profile

An Open-Label Extension Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects Ages 1 to less than 11 Years: a Long Term Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Sep 2017

At a glance

  • Drugs Candesartan cilexetil (Primary)
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms HIP
  • Sponsors AstraZeneca
  • Most Recent Events

    • 09 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Dec 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 13 Mar 2009 Status changed from recruiting to active, no longer recruiting, according to clinicaltrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top